GnRHa trigger for final oocyte maturation: Is HCG trigger history?

Reproductive BioMedicine Online

Volumn 29, Issue 3, 2014, Pages 274-280

  Humaidan, Peter ^a,b   Alsbjerg, Birgit ^b  

^a AARHUS UNIVERSITY   (Denmark)

^b SKIVE REGIONAL HOSPITAL   (Denmark)

Author keywords

GnRHa; HCG; IVF; Luteal phase support; OHSS; Ovulation trigger

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; STEROID; FERTILITY PROMOTING AGENT;

BREAST CANCER; COMPARATIVE STUDY; DISEASE SEVERITY; DOWN REGULATION; EMBRYO TRANSFER; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; HUMAN; LOW RISK POPULATION; LUTEAL INSUFFICIENCY; LUTEAL PHASE; OOCYTE MATURATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ANALOGS AND DERIVATIVES; DRUG EFFECTS; FEMALE; OOCYTE DEVELOPMENT; OVULATION INDUCTION; PREGNANCY; PROCEDURES;

FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOGENESIS; OVULATION INDUCTION; PREGNANCY;

EID: 84925622656     PISSN: 14726483     EISSN: 14726491     Source Type: Journal    
DOI: 10.1016/j.rbmo.2014.05.008     Document Type: Review

References (66)

1. Acevedo, B., Gomez-Palomares, J.L., Ricciarelli, E., Hernandez, E.R., 2006. Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil. Steril. 86, 1682-1687.
2. Babayof, R., Margalioth, E.J., Huleihel, M., Amash, A., Zylber-Haran, E., Gal, M., Brooks, B., Mimoni, T., Eldar-Geva, T., 2006. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Hum. Reprod. 21, 1260-1265.
3. Belva, F., Henriet, S., Van den Abbeel, E., Camus, M., Devroey, P., Van der Elst, J., Liebaers, I., Haentjens, P., Bonduelle, M., 2008. Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. Hum. Reprod. 23, 2227-2238.
4. Bermejo, A., Cerrillo, M., Ruiz-Alonso, M., Blesa, D., Simon, C., Pellicer, A., Garcia-Velasco, J.A., 2014. Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression. Fertil. Steril. 101, 138-146.
5. Castillo, J.C., Dolz, M., Bienvenido, E., Abad, L., Casan, E.M., Bonilla-Musoles, F., 2010. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support. Reprod. Biomed. Online 20, 175-181.
6. Cerrillo, M., Rodriguez, S., Mayoral, M., Pacheco, A., Martinez-Salazar, J., Garcia-Velasco, J.A., 2009. Differential regulation of VEGF after final oocyte maturation with GnRH agonist versus HCG: a rationale for OHSS reduction. Fertil. Steril. 91, 1526-1528.
7. De Ziegler, D., Shoham, Z., 2013. Triggering of ovulation with GnRHa in ART: worldwide feedback on an emerging new option with great potential. Available from: 〈http://www.ivf-worldwide.com/survey/vitrification,-gnrh-trigger-and-differed-et/resultsvitrification,-gnrh-trigger-and-differed-et.html〉.
8. Delvigne, A., Rozenberg, S., 2002. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review. Hum. Reprod. Update 8, 559-577.
9. Devroey, P., Polyzos, N.P., Blockeel, C., 2011. An OHSS-Free Clinic by segmentation of IVF treatment. Hum. Reprod. 26, 2593-2597.
10. Engmann, L., Siano, L., Schmidt, D., Nulsen, J., Maier, D., Benadiva, C., 2006. GnRH agonist to induce oocyte maturation during IVF in patients at high risk of OHSS Reprod. Biomed. Online 13, 639-644.
11. Engmann, L., DiLuigi, A., Schmidt, D., Benadiva, C., Maier, D., Nulsen, J., 2008. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study. Fertil. Steril. 89, 554-561.
12. Evans, J., Salamonsen, L.A., 2013. Too much of a good thing? Experimental evidence suggests prolonged exposure to HCG is detrimental to endometrial receptivity. Hum. Reprod. 28, 1610-1619.
13. Fatemi, H., Popovic-Todorovic, B., Humaidan, P., Kol, S., Banker, M., Devroey, P., Garcia-Velasco, J.A., 2014. Severe OHSS following GnRH agonist trigger and "freeze all" approach in GnRH antagonist protocol. Fertil. Steril. 101, 1008-1011.
14. Forman, R., Fries, N., Testart, J., Belaisch-Allart, J., Hazout, A., Frydman, R., 1988. Evidence for an adverse effect of elevated serum estradiol concentrations on embryo implantation. Fertil. Steril. 49, 118-122.
15. Galindo, A., Bodri, D., Guillen, J.J., Colodron, M., Vernaeve, V., Coll, O., 2009. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol. Endocrinol. 25, 60-66.
16. Garcia-Velasco, J.A., 2012. Agonist trigger: what is the best approach? Agonist trigger with vitrification of oocytes or embryos. Fertil. Steril. 97, 527-528.
17. Gonen, Y., Balakier, H., Powell, W., Casper, R.F., 1990. Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J. Clin. Endocrinol. Metab. 71, 918-922.
18. Griesinger, G., Kolibianakis, E.M., Papanikolaou, E.G., Diedrich, K., Van Steirteghem, A., Devroey, P., Ejdrup, B.H., Humaidan, P., 2007. Triggering of final oocyte maturation with gonadotropinreleasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. Fertil. Steril. 88, 616-621.
19. Griffin, D., Engmann, L., Budinetz, T., Kummer, N., Nulsen, J., Benadiva, C., 2012a. Dual trigger with gonadotropin releasing hormone agonist (GnRHa) and human chorionic gonadotropin (HCG)for the treatment of "immature oocyte syndrome" (IOS). ASRM 153.
20. Griffin, D., Benadiva, C., Kummer, N., Budinetz, T., Nulsen, J., Engmann, L., 2012b. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil. Steril. 97, 1316-1320.
21. Gustofson, R.L., Segars, J.H., Larsen, F.W., 2006. Ganirelix acetate causes a rapid reduction in estradiol levels without adversely affecting oocyte maturation in women pretreated with leuprolide acetate who are at risk of ovarian hyperstimulation syndrome. Hum. Reprod. 21, 2830-2837.
22. Henningsen, A.K., Romundstad, L.B., Gissler, M., Nygren, K.G., Lidegaard, O., Skjaerven, R., Tiitinen, A., Andersen, A.N., Wennerholm, U.B., Pinborg, A., 2011. Infant and maternal health monitoring using a combined Nordic database on ART and safety. Acta Obstet. Gynecol. Scand. 90, 683-691.
23. Hernandez, E.R., Gomez-Palomares, J.L., Ricciarelli, E., 2009. No room for cancellation, coasting, or ovarian hyperstimulation syndrome in oocyte donation cycles. Fertil. Steril. 91, 1358-1361.
24. Hill, M.J., Chason, R.J., Payson, M.D., Segars, J.H., Csokmay, J.M., 2012. GnRH antagonist rescue in high responders at risk for OHSS results in excellent assisted reproduction outcomes. Reprod. Biomed. Online 25, 284-291.
25. Humaidan, P., 2009. Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod. Biomed. Online 18, 630-634.
26. Humaidan, P., Bredkjaer, H.E., Bungum, L., Bungum, M., Grondahl, M.L., Westergaard, L., Andersen, C.Y., 2005. GnRH agonist (buserelin) or HCG for ovulation induction in GnRH antagonist IVF/ ICSI cycles: a prospective randomized study. Hum. Reprod. 20, 1213-1220.
27. Humaidan, P., Bungum, L., Bungum, M., Yding, A.C., 2006a. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod. Biomed. Online 13, 173-178.
28. Humaidan, P., Bungum, L., Bungum, M., Yding, A.C., 2006b. Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod. Biomed. Online 13, 173-178.
29. Humaidan, P., Ejdrup, B.H., Westergaard, L.G., Yding, A.C., 2010. 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil. Steril. 93, 847-854.
30. Humaidan, P., Kol, S., Papanikolaou, E.G., 2011. GnRH agonist for triggering of final oocyte maturation: time for a change of practice? Hum. Reprod. Update 17, 510-524.
31. Humaidan, P., Van Vaerenbergh, I., Bourgain, C., Alsbjerg, B., Blockeel, C., Schuit, F., Van Lommel, L., Devroey, P., Fatemi, H., 2012. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Hum. Reprod. 27, 3259-3272.
32. Humaidan, P., Polyzos, N.P., Alsbjerg, B., Erb, K., Mikkelsen, A.L., Elbaek, H.O., Papanikolaou, E.G., Andersen, C.Y., 2013a. GnRHa trigger and individualized luteal phase HCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients. Hum. Reprod. 28, 2511-2521.
33. Humaidan, P., Thomsen, L.H., Alsbjerg, B., 2013b. GnRHa trigger and modified luteal support with one bolus of HCG should be used with caution in extreme responder patients. Hum. Reprod. 28, 2593-2594.
34. Iliodromiti, S., Blockeel, C., Tremellen, K.P., Fleming, R., Tournaye, H., Humaidan, P., Nelson, S.M., 2013a. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study. Hum. Reprod. 28, 2529-2536.
35. Iliodromiti, S., Lan, V.T., Tuong, H.M., Tuan, P.H., Humaidan, P., Nelson, S.M., 2013b. Impact of GnRH agonist triggering and intensive luteal steroid support on live-birth rates and ovarian hyperstimulation syndrome: a retrospective cohort study. J. Ovarian Res. 6, 93.
36. Imbar, T., Kol, S., Lossos, F., Bdolah, Y., Hurwitz, A., Haimov-Kochman, R., 2012. Reproductive outcome of fresh or frozen-thawed embryo transfer is similar in high-risk patients for ovarian hyperstimulation syndrome using GnRH agonist for final oocyte maturation and intensive luteal support. Hum. Reprod. 27, 753-759.
37. Imoedemhe, D.A., Sigue, A.B., Pacpaco, E.L., Olazo, A.B., 1991. Stimulation of endogenous surge of LH with gonadotropinreleasing hormone analog after ovarian stimulation for in vitro fertilization. Fertil. Steril. 55, 328-332.
38. Itskovitz, J., Boldes, R., Levron, J., Erlik, Y., Kahana, L., Brandes, J.M., 1991. Induction of preovulatory LH surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil. Steril. 56, 213-220.
39. Itskovitz-Eldor, J., Kol, S., Mannaerts, B., Coelingh, B.H., 1998. First established pregnancy after controlled ovarian hyperstimulation with recombinant follicle stimulating hormone and the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462). Hum. Reprod. 13, 294-295.
40. Kol, S., Humaidan, P., Itskovitz-Eldor, J., 2011. GnRH agonist ovulation trigger and HCG-based, progesterone-free luteal support: a proof of concept study. Hum. Reprod. 26, 2874-2877.
41. Kolibianakis, E.M., Schultze-Mosgau, A., Schroer, A., Van Steirteghem, A., Devroey, P., Diedrich, K., Griesinger, G., 2005. A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Hum. Reprod. 20, 2887-2892.
42. Maheshwari, A., Bhattacharya, S., 2013. Elective frozen replacement cycles for all: ready for prime time? Hum. Reprod. 28, 69.
43. Maheshwari, A., Pandey, S., Shetty, A., Hamilton, M., Bhattacharya, S., 2012. Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of frozen thawed versus fresh embryos generated through in vitro fertilization treatment: a systematic review and meta-analysis. Fertil. Steril. 98, 368-377.
44. Martinez, F., Rodriguez, D.B., Buxaderas, R., Tur, R., Mancini, F., Coroleu, B., 2011. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports. Fertil. Steril. 95, 2432-2439.
45. Martinez, F., Mancini, F., Sole, M., Jose, G.M., Beatriz, R.D., Buxaderas, R., Rodriguez, I., Nolasc, B.P., 2014. Antagonist rescue of agonist IVF cycle at risk of OHSS: a case series. Gynecol. Endocrinol. 30, 145-148.
46. Melo, M., Busso, C.E., Bellver, J., Alama, P., Garrido, N., Meseguer, M., Pellicer, A., Remohi, J., 2009. GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reprod. Biomed. Online 19, 486-492.
47. Oktay, K., Turkcuoglu, I., Rodriguez-Wallberg, K.A., 2010. GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor/FSH stimulation. Reprod. Biomed. Online 20, 783-788.
48. Orvieto, R., 2012. Intensive luteal-phase support with oestradiol and progesterone after GnRH-agonist triggering: does it help? Reprod. Biomed. Online 24, 680-681.
49. Orvieto, R., Rabinson, J., Meltzer, S., Zohav, E., Anteby, E., Homburg, R., 2006. Substituting HCG with GnRH agonist to trigger final follicular maturation-a retrospective comparison of three different ovarian stimulation protocols. Reprod. Biomed. Online 13, 198-201.
50. Ozkaya, E., San, R.G., Oktay, K., 2012. Luteal phase GnRHa trigger in random start fertility preservation cycles. J. Assist. Reprod. Genet. 29, 503-505.
51. Papanikolaou, E.G., Verpoest, W., Fatemi, H., Tarlatzis, B., Devroey, P., Tournaye, H., 2011. A novel method of luteal supplementation with recombinant LH when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. Fertil. Steril. 95, 1174-1177.
52. Pinborg, A., Loft, A., Henningsen, A.K., Ziebe, S., 2012. Does assisted reproductive treatment increase the risk of birth defects in the offspring? Acta Obstet. Gynecol. Scand. 91, 1245-1246.
53. Porter, R.N., Smith, W., Craft, I.L., Abdulwahid, N.A., Jacobs, H.S., 1984. Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins. Lancet 2, 1284-1285.
54. Radesic, B., Tremellen, K., 2011. Oocyte maturation employing a GnRH agonist in combination with low-dose HCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates. Hum. Reprod. 26, 3437-3442.
55. Seyhan, A., Ata, B., Polat, M., Son, W.Y., Yarali, H., Dahan, M.H., 2013. Severe early ovarian hyperstimulation syndrome following GnRH agonist trigger with the addition of 1500 IU HCG. Hum. Reprod. 28, 2522-2528.
56. Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Thomas, S., 2008. Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil. Steril. 90, 231-233.
57. Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Hudson, C., 2011a. Comparison of "triggers" using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. Fertil. Steril. 95, 2715-2717.
58. Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Hudson, C., Thomas, S., 2011b. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil. Steril. 96, 344-348.
59. Sismanoglu, A., Tekin, H.I., Erden, H.F., Ciray, N.H., Ulug, U., Bahceci, M., 2009. Ovulation triggering with GnRH agonist vs. HCG in the same egg donor population undergoing donor oocyte cycles with GnRH antagonist: a prospective randomized crossover trial. J. Assist. Reprod. Genet. 26, 251-256.
60. Sonmezer, M., Turkcuoglu, I., Coskun, U., Oktay, K., 2011. Randomstart controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles. Fertil. Steril. 95, e9-e11, 2125.
61. Tomas, C., Alsbjerg, B., Martikainen, H., Humaidan, P., 2012. Pregnancy loss after frozen-embryo transfer-a comparison of three protocols. Fertil. Steril. 98, 1165-1169.
62. Tur-Kaspa, I., Fauser, B., 2013. Survey: the use of GnRHagonist in IVF protocols. Available from: 〈http://www.ivf-worldwide.com/survey/the-use-of-gnrh-agonist-in-ivf-protocols/results-the-useof-gnrh-agonist-in-ivf-protocols.html〉.
63. Valbuena, D., Martin, J., De Pablo, J.L., Remohi, J., Pellicer, A., Simon, C., 2001. Increasing levels of estradiol are deleterious to embryonic implantation because they directly affect the embryo. Fertil. Steril. 76, 962-968.
64. Weissman, A., Lurie, S., Zalel, Y., Goldchmit, R., Shoham, Z., 1996. Human chorionic gonadotropin: pharmacokinetics of subcutaneous administration. Gynecol. Endocrinol. 10, 273-276.
65. Yding, A.C., Leonardsen, L., Ulloa-Aguirre, A., Barrios-De-Tomasi, J., Moore, L., Byskov, A.G., 1999. FSH-induced resumption of meiosis in mouse oocytes: effect of different isoforms. Mol. Hum. Reprod. 5, 726-731.
66. Zelinski-Wooten, M.B., Hutchison, J.S., Hess, D.L., Wolf, D.P., Stouffer, R.L., 1995. Follicle stimulating hormone alone supports follicle growth and oocyte development in gonadotrophinreleasing hormone antagonist-treated monkeys. Hum. Reprod. 10, 1658-1666.